InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,321.41
(
0.25%
)
US TECH 100
18,240.00
(
0.04%
)
Dow Jones
39,872.99
(
0.00%
)
Brent Oil
81.97
(
-0.58%
)
Bitcoin
69,926.56
(
-0.29%
)
Post# of 424420
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Jvee

Send PM Follow Ignore
Followers 7
Posts 155
Boards Moderated 0
Alias Born 10/20/2018

Jvee

Re: venus537 post# 171957

Saturday, 01/12/2019 4:38:06 PM

Saturday, January 12, 2019 4:38:06 PM

Post# of 424420
Points taken but we can assume that overall revenue run rate post 2029 will / should decline, otherwise why would BPs be concerned with their products going generic?

Yes potentially there may be other drugs deprived from V for an acquirer but that potential will factor little if any in a BO price.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Start posting your company's news
Only $200 per official company press release!